Tuesday, October 24, 2006 5:00 p.m. - 8:00 p.m. Registration - Salons E-H, La Jolla Ballroom Foyer 6:00 p.m. - 8:00 p.m. Commercialization Forum - Salons F-H, La Jolla Ballroom Session Chair: Sadik C. Esener, Ph.D. University of California, San Diego Invited Speakers: Patrick Soon-Shiong, M.D. Chairman of the Board and Chief Executive Officer Abraxis BioScience, Inc. Andrew "Drew" E. Senyei, M.D. General Partner and Managing Director Enterprise Partners Venture Capital Claude D. Benchimol, Ph.D. Senior Vice President of Research and Development Invitrogen Corporation David R. Parkinson, M.D. Senior Vice President, Oncology Research and Development Biogen Idec Wednesday, October 25, 2006 7:00 a.m. - 6:30 p.m. Registration - Salons E-H, La Jolla Ballroom Foyer 7:00 a.m. - 8:00 a.m. Breakfast - Salons E-H, La Jolla Ballroom Foyer 8:00 a.m. - 8:30 a.m. Opening Remarks - Salons E-H, La Jolla Ballroom Anna D. Barker, Ph.D. Deputy Director, Advanced Technologies and Strategic Partnerships National Cancer Institute, NIH Sadik C. Esener, Ph.D. University of California, San Diego 8:30 a.m. - 9:00 a.m. Plenary Presentation - Salons E-H, La Jolla Ballroom Clinical Promise of Nanomedicine: Delivery and Penetration of Pathways Into Solid Tumors Jan E. Schnitzer, M.D. Scientific Director Sidney Kimmel Cancer Center 9:00 a.m. - 10:00 a.m. Session I: In Vivo Diagnostics and Imaging - Salons E-H, La Jolla Ballroom Session Chair: Sanjiv Sam Gambhir, M.D., Ph.D. Stanford University NCI Moderator: Jerry S.H. Lee, Ph.D. National Cancer Institute, NIH Speakers: Improved Magnetofluorescent Nanoparticles for Cancer Detection Lee Josephson, Ph.D. Harvard Medical School and Massachusetts General Hospital In Vivo Imaging With Quantum Dots Jianghong Rao, Ph.D. Stanford University PET Imaging and Use of Microfluidics for Rapid Synthesis of Radiolabeled Molecular Imaging Probes Michael E. Phelps, Ph.D. University of California, Los Angeles Bioactivated Nanoprobes for Molecular Imaging of Cancer Thomas J. Meade, Ph.D. Northwestern University 10:00 a.m. - 10:30 a.m. Discussion - Salons E-H, La Jolla Ballroom 10:30 a.m. - 10:45 a.m. Break 10:45 a.m. - 11:15 a.m. Session I: In Vivo Diagnostics and Imaging (continued): Research Enablers (Animal Model/Toxicology) - Salons E-H, La Jolla Ballroom Speakers: Intraperitoneally Administered Nanoporous Silicon Particles for the Treatment of Ovarian Cancer Stephen B. Howell, M.D. University of California, San Diego Molecularly Tailored Mouse Models of Cancer for In Vivo Applications of Nanomedical Sciences Alan Charest, Ph.D. Massachusetts Institute of Technology 11:15 a.m. - 11:45 a.m. Discussion - Salons E-H, La Jolla Ballroom 11:45 a.m. - 2:00 p.m. Lunch - First Floor, Fountain Court (Lunch will stop being served at 1:30 p.m.) Poster Session I - First Floor, Newport and Irvine and Salons E-H Foyer 12 noon - 1:00 p.m. Bioinformatics in Nanotechnology Working Group Luncheon - Third Floor, Santa Barbara Room 2:00 p.m. - 2:30 p.m. Keynote Presentating - Salons E-H, La Jolla Ballroom Thomas Kalil Special Assistant to the Chancellor for Science and Technology University of California, Berkeley 2:30 p.m. - 3:45 p.m. Session II: Nanotherapeutics - Salons E-H, La Jolla Ballroom Session Chair: Gregory M. Lanza, M.D., Ph.D. Washington University in Saint Louis NCI Moderator: Linda K. Molnar, Ph.D. National Cancer Institute, NIH Speakers: Targeting Nanoparticles to the Tumor Endothelium David A. Cheresh, Ph.D. University of California, San Diego Nanotechnology in Drug Delivery James R. Baker, Jr., M.D. University of Michigan Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer-Nanoparticle Conjugate Tayyaba Hasan, Ph.D. Harvard Medical School and Massachusetts General Hospital Nanoparticle Therapeutics: Examples and Outlook Samuel A. Wickline, M.D. Washington University in Saint Louis How Can the NCI Nanotechnology Alliance Access the Drug Development Capabilities of the NCI? Joseph Tomaszewski, Ph.D. Deputy Director, Division of Cancer Treatment and Diagnosis National Cancer Institute, NIH 3:45 p.m. - 4:15 p.m. Discussion - Salons E-H, La Jolla Ballroom 4:15 p.m. - 4:30 p.m. Break 4:30 p.m. - 5:15 p.m. Session II: Nanotherapeutics (continued): Research Enablers (Targeting Strategies) - Salons E-H, La Jolla Ballroom Speakers: Targeting Strategies: Engineered Antibodies and Proteins Anna M. Wu, Ph.D. University of California, Los Angeles Ligand-Directed Perfluorocarbon Nanoparticles: The Issue of Targeting Gregory M. Lanza, M.D., Ph.D. Washington University in Saint Louis Aptamers and Cancer Nanotechnology Omid Farokhzad, M.D. Brigham and Women's Hospital and Harvard Medical School 5:15 p.m. - 5:45 p.m. Discussion - Salons E-H, La Jolla Ballroom 6:30 p.m. - 10:00 p.m. Evening Event: Birch Aquarium at Scripps 2300 Expedition Way, La Jolla, California     6:30 p.m.     Buses depart for the Birch Aquarium at Scripps.     Hotel Lobby Buses run consistently from 6:30 p.m. - 10:00 p.m.     6:30 p.m. - 7:15 p.m.     Reception     7:15 p.m. - 8:00 p.m.     Dinner     8:00 p.m. - 8:30 p.m.     Keynote Presentation:     Evolution of Cancer Therapeutics     David R. Parkinson, M.D.     Senior Vice President, Oncology Research and Development     Biogen Idec     10:00 p.m.     Last bus leaves the Birch Aquarium at Scripps for the hotel. Thursday, October 26, 2006 7:30 a.m. - 5:00 p.m. Registration - Salons E-H, La Jolla Ballroom Foyer 7:30 a.m. - 8:25 a.m. Breakfast - Salons E-H, La Jolla Ballroom Foyer 8:25 a.m. - 8:30 a.m. Morning Remarks - Salons E-H, La Jolla Ballroom Piotr Grodzinski, Ph.D. National Cancer Institute, NIH 8:30 a.m. - 9:45 a.m. Session III: Nanomaterials in Biological Matrices - Salons E-H, La Jolla Ballroom Session Chair: Mauro Ferrari, Ph.D. University of Texas Health Science Center, Houston NCI Moderator: Travis M. Earles National Cancer Institute, NIH Speakers: "Mother Ships" for Nanodiagnostics and Nanotherapeutics Michael J. Sailor, Ph.D. University of California, San Diego Bridging the Imaging Gap in Nanobiology With Three-Dimensional Electron Microscopy Sriram Subramaniam, Ph.D. National Cancer Institute, NIH Multifunctional Nanoparticle Probes for In Vivo Cancer Imaging Shuming Nie, Ph.D. Georgia Institute of Technology and Emory University Anti-Biobarrier Nanotechnologies Mauro Ferrari, Ph.D. University of Texas Health Science Center, Houston Organic Delivery Vehicles for Probing and Treating Biological Systems: Adapting Fabrication Processes From the Electronics Industry for Use in Nanomedicine Joseph M. DeSimone, Ph.D. The University of North Carolina at Chapel Hill 9:45 a.m. - 10:15 a.m. Discussion - Salons E-H, La Jolla Ballroom 10:15 a.m. - 10:30 a.m. Break 10:30 a.m. - 11:10 a.m. Panel: Clinical Pathways for Nanotechnology - Salons E-H, La Jolla Ballroom Speakers: Characterization of Nanomaterials Intended for Medical Applications Scott E. McNeil, Ph.D. Director, Nanotechnology Characterization Laboratory SAIC-Frederick, Inc. National Cancer Institute, NIH Nanotechnology: Stimulating Innovation Through Collaboration With the U.S. Food and Drug Administration Wendy R. Sanhai, Ph.D. Senior Scientific Advisor, Office of the Commissioner U.S. Food and Drug Administration Medical Nanodevices - Regulatory Perspectives Subhas G. Malghan, Ph.D. Deputy Director Center for Devices and Radiological Health U.S. Food and Drug Administration 11:10 a.m. - 11:30 a.m. Question and Answer Session - Salons E-H, La Jolla Ballroom 11:30 a.m. - 12 noon Multidisciplinary Research Training and Team Development - Salons E-H, La Jolla Ballroom NCI Moderator: Travis M. Earles National Cancer Institute, NIH Speakers: Sri Sridhar, Ph.D. Northeastern University Carolyn J. Anderson, Ph.D. Washington University in Saint Louis Joanne Mortimer, M.D. University of California, San Diego 11:30 a.m. - 1:45 p.m. Poster Session II - First Floor, Newport and Irvine and Salons E-H Foyer 12 noon - 1:45 p.m. Lunch - First Floor, Fountain Court (Lunch will stop being served at 1:30 p.m.) 12:15 p.m. - 1:45 p.m. Coordinating and Governance Committee (CGC) Luncheon Meeting - Third Floor, San Francisco (invitation only) 1:45 p.m. - 2:45 p.m. Session IV: In Vitro Diagnostics - Salons E-H, La Jolla Ballroom Session Chair: James R. Heath, Ph.D. California Institute of Technology NCI Moderator: Piotr Grodzinski, Ph.D. National Cancer Institute, NIH Speakers: Integrated System for Cancer Biomarker Detection Scott Manalis, Ph.D. Massachusetts Institute of Technology Simultaneous and Quantitative Detection of Multiple Biomarkers in Human Breast Cancers Using Semiconductor Multicolor Quantum Dots Ruth M. O'Regan, M.D. Emory University Carbon Nanomaterials for Biological Applications Hongjie Dai, Ph.D. Stanford University Deconstructing Directional Cell Motility in Cancer Metastasis Through Nanopatterning Bartosz A. Grzybowski, Ph.D. Northwestern University 2:45 p.m. - 3:15 p.m. Discussion - Salons E-H, La Jolla Ballroom 3:15 p.m. - 3:30 p.m. Break 3:30 p.m. - 4:15 p.m. Session IV: In Vitro Diagnostics (continued): Research Enablers (Capture Agents/Technology Scale-Up) - Salons E-H, La Jolla Ballroom Speakers: Molecular Profiling of Murine Models and Human Prostate Cancer for Pathway-Specific Biomarker Discovery Thomas Graeber, Ph.D. University of California, Los Angeles Science and Regulatory Perspectives of Medical Devices Using Nanotechnology Subhas G. Malghan, Ph.D. Deputy Director Center for Devices and Radiological Health U.S. Food and Drug Administration Commercialization of Life Sciences Technologies: An Experience J. Michael Ramsey, Ph.D. The University of North Carolina at Chapel Hill 4:15 p.m. - 4:45 p.m. Discussion - Salons E-H, La Jolla Ballroom 4:45 p.m. - 5:00 p.m. Closing Remarks - Salons E-H, La Jolla Ballroom 5:00 p.m. Adjournment
Home  -  Agenda  -  Photo Gallery  -  Nano 2007